Thiotepa eyedrops to prevent pterygium recurrences. 18 years of utilization;Collyre thiotepa pour prevenir les recidives des pterygions. 18 ans d'utilisation

Journal Francais d'Ophtalmologie

Volumn 22, Issue 2, 1999, Pages 215-219

  Tassy, A ^a   Ribe, D ^a  

^a Hopital Font Pre   (France)

Author keywords

Pterygium; Recurrence; Thiotepa

Indexed keywords

FLUOROURACIL; MITOMYCIN C; THIOTEPA; ANTINEOPLASTIC AGENT; EYE DROPS;

ARTICLE; DRUG EFFICACY; DRUG SAFETY; EYE SURGERY; HUMAN; MAJOR CLINICAL STUDY; PTERYGIUM; RECURRENT DISEASE; SURGICAL TECHNIQUE; TOPICAL DRUG ADMINISTRATION; ADULT; AGED; COMPARATIVE STUDY; FOLLOW UP; MIDDLE AGED; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PTERYGIUM; RECURRENCE; THIOTEPA; TIME FACTORS;

EID: 0032944278     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Meacham CT. Triethylene thiophosphoramide in the prevention of pterygium recurrence. Am J Ophthalmol 1962; 54: 751-3.
2. Cassady JR. The inhibition of pterygium reccurence by thiotepa. Am J Ophthalmol 1966; 61: 886-8.
3. Liddy BSL, Morgan JF. Triethylene thiophosphoramide (Thiotepa) and pterygium. Am J Ophthalmol 1966; 6: 888-90.
4. Kleis W, Pico G. Thio-tepa therapy to prevent postoperative pterygium occurence and neovascularization. Am J Ophthalmol 1973; 76: 371-2.
5. Chapman-Smith JS. Pterygium treatment with triethylene thiophosphoramide. Aust N Z J Ophthalmol 1992; 20: 129-31.
6. Ngoy D, Kayembe L. Étude comparative du Thio-tépa et de la Mitomycine C dans le traitement du ptérygion. J Fr Ophtalmol 1998; 21: 96-102.
7. Gourcuff A, Tassy A, Garron J, et al. Thiotépa en collyre pour les récidives de ptérygion et de néo-vascularisation de cornée. Bull Soc Ophtalmol Fr 1984; 84: 583-7.
8. Cornand G. Le ptérygion. Évolution et traitement. J Fr Ophtalmol 1990; 13: 33-45.
9. Cornand G. Le ptérygion. Evolution et traitement. Rev Int Trach Pathol Ocul Trop 1989; 3-4: 31-76.
10. Hervouet F. Cure chirurgicale du ptérygion. Ann Oculist 1973; 296: 49-56.
11. e édition). Chartres: Luneau ophtalmologie, 1987.
12. Anthony P, Adamis AP, Stark T, Kenyon KR. The management of pterygium. Ophthalmol Clinics North America 1990; 3: 611-23.
13. Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sciera excision. Arch Ophthalmol 1997; 115: 1235-40.
14. Flament J, Speeg-Schatz C, Weber M. État actuel du traitement du ptérygion. J Fr Ophtalmol 1993; 16: 401-10.
15. Mori S. A new treatment of pterygium. Acta Soc Ophthalmol Jpn 1962; 66: 990.
16. Asregadoo ER. Surgery, thio-tepa, and corticosteroid in the treatment of pterygium. Am J Ophthalmol 1972; 74: 960-3.
17. Olander K, Haik KG, Haik GM. Management of pterygia: should thiotepa be used? Ann Ophthalmol 1978 ; 10: 853-62.
18. Carlentini S, Toschi PG, Conci P, et al. Impiego del 5-Fluorouracile nel trattamento dello pterygio recidivante. Nostra esperienza. Ann Ottalmol Clin Ocul 1991; 117: 1197-202.
19. Ledererova D, Pracharova Z, Valkova Z, Vymazal M. Results of surgical treatment of pterygium. Cesk Slov Oftalmol 1997; 53: 190-4.
20. Hardten DR. Mitomycin linked to corneal melt. Ocular Surgery News Int Ed 1994; 5: 11: 15.
21. Rubinfeld RS, Stein RM. Topical mitomycin-C for pterygia: is single application appropriate? Ophthalmic Surg Lasers 1997; 28: 662-9.